loadpatents
name:-0.070688962936401
name:-0.031858921051025
name:-0.0077810287475586
Simard; John Patent Filings

Simard; John

Patent Applications and Registrations

Patent applications and USPTO patent grants for Simard; John.The latest application filed is for "compositions and methods for treating and preventing staphylococcus aureus infections".

Company Profile
8.39.68
  • Simard; John - Austin TX
  • Simard; John - Vancouver CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions and methods for treating and preventing staphylococcus aureus infections
App 20220251175 - Simard; John
2022-08-11
Arthritis treatment
Grant 11,390,672 - Simard July 19, 2
2022-07-19
Antibody Formulation
App 20220220196 - SIMARD; John
2022-07-14
Compositions and methods for treating and preventing Staphylococcus aureus infections
Grant 11,370,831 - Simard June 28, 2
2022-06-28
Treatment Of Psychiatric Conditions
App 20220062413 - SIMARD; John
2022-03-03
Treatment of brain ischemia-reperfusion injury
App 20220041710 - Camici; Giovanni Guido ;   et al.
2022-02-10
Treating Vascular Disease And Complications Thereof
App 20210403548 - SIMARD; John
2021-12-30
Treatment of psychiatric conditions
Grant 11,191,831 - Simard December 7, 2
2021-12-07
Treatment Of Atopic Dermatitis
App 20210238273 - Simard; John
2021-08-05
Human Antibody Specific For Interleukin-1alpha
App 20210171623 - SIMARD; John
2021-06-10
Human antibody specific for interleukin-1 alpha
Grant 10,899,833 - Simard January 26, 2
2021-01-26
Compositions and Methods for Treating and Preventing Staphylococcus Aureus Infections
App 20210017257 - Simard; John
2021-01-21
Compositions and methods for treating and preventing staphylococcus aureus infections
App 20200131252 - Simard; John
2020-04-30
Immunoglobulin Variable Region Libraries
App 20200071388 - Simard; John
2020-03-05
Compositions and methods for treating and preventing Staphylococcus aureus infections
Grant 10,577,410 - Simard
2020-03-03
Arthritis Treatment
App 20190352391 - Simard; John
2019-11-21
Treatment Of Cancer With Anti-il-1 Alpha Antibodies
App 20190169287 - Simard; John
2019-06-06
Treatment for neoplastic diseases
Grant 10,294,296 - Simard
2019-05-21
Compositions and methods for treating and preventing staphylococcus aureus infections
App 20190127449 - Simard; John
2019-05-02
Treatment for neoplastic diseases
App 20190127460 - Simard; John
2019-05-02
Compositions and methods for treating and preventing Staphylococcus aureus infections
Grant 10,214,581 - Simard Feb
2019-02-26
Cachexia treatment
Grant 10,202,449 - Simard Feb
2019-02-12
Treatment Of Psychiatric Conditions
App 20180360960 - Simard; John
2018-12-20
Treatment of diabetes
Grant 9,988,447 - Simard June 5, 2
2018-06-05
Human Antibody Specific for Interleukin-1alpha
App 20180127495 - Simard; John
2018-05-10
Treating Vascular Disease And Complications Thereof
App 20180057585 - Simard; John
2018-03-01
Treatment of dermatological pathologies
Grant 9,902,769 - Simard February 27, 2
2018-02-27
Cachexia Treatment
App 20180037647 - Simard; John
2018-02-08
Human antibody specific for interleukin-1alpha
Grant 9,840,558 - Simard December 12, 2
2017-12-12
Compositions and Methods for Treating and Preventing Staphylococcus Aureus Infections
App 20170349648 - Simard; John
2017-12-07
Cachexia treatment
Grant 9,809,649 - Simard November 7, 2
2017-11-07
Compositions and methods for treating and preventing Staphylococcus aureus infections
Grant 9,783,598 - Simard October 10, 2
2017-10-10
Immunoglobulin Variable Region Libraries
App 20170233457 - Simard; John
2017-08-17
Treatment of inflammatory skin disease
Grant 9,724,409 - Simard August 8, 2
2017-08-08
Immunoglobulin variable region libraries
Grant 9,670,483 - Simard June 6, 2
2017-06-06
Treatment of Diabetes
App 20170081403 - Simard; John
2017-03-23
Compositions and Methods for Treating and Preventing Staphylococcus Aureus Infections
App 20170015734 - Simard; John
2017-01-19
Arthritis Treatment
App 20170002071 - Simard; John
2017-01-05
Treatment of Dermatological Pathologies
App 20160368982 - Simard; John
2016-12-22
Immunoglobulin Variable Region Libraries
App 20160362679 - Simard; John
2016-12-15
Compositions and methods for treating and preventing Staphylococcus aureus infections
Grant 9,486,523 - Simard November 8, 2
2016-11-08
Compositions and Methods for Treating and Preventing Staphylococcus Aureus Infections
App 20160279243 - Simard; John
2016-09-29
Identifying affinity-matured human antibodies
Grant 9,453,217 - Simard September 27, 2
2016-09-27
Compositions and methods for treating and preventing Staphylococcus aureus infections
Grant 9,416,172 - Simard August 16, 2
2016-08-16
Identifying affinity-matured human antibodies
Grant 9,394,536 - Simard July 19, 2
2016-07-19
Treatment Of Cancer With Anti-il-1 Alpha Antibodies
App 20160159899 - Simard; John
2016-06-09
Identifying Affinity-matured Human Antibodies
App 20160060618 - Simard; John
2016-03-03
Identifying Affinity-matured Human Antibodies
App 20160060619 - Simard; John
2016-03-03
Human Antibody Specific for Interleukin-1alpha
App 20160024202 - Simard; John
2016-01-28
Identifying affinity-matured human antibodies
Grant 9,234,030 - Simard January 12, 2
2016-01-12
Compositions and Methods for Treating and Preventing Staphylococcus Aureus Infections
App 20150344548 - Simard; John
2015-12-03
Human antibody specific for IL-1alpha
Grant 9,181,338 - Simard November 10, 2
2015-11-10
Human Antibody Specific for IL-1alpha
App 20150094455 - Simard; John
2015-04-02
Interleukin-1.alpha. antibodies and methods of use
Grant 8,962,814 - Simard February 24, 2
2015-02-24
Nucleic acids encoding a human monoclonal antibody that specifically binds to IL-1.alpha.
Grant 8,956,831 - Simard February 17, 2
2015-02-17
Increasing anti-IL-1.alpha. antibodies in a subject
Grant 8,865,175 - Simard , et al. October 21, 2
2014-10-21
Method for killing IL-1 alpha expressing cells
Grant 8,784,817 - Simard July 22, 2
2014-07-22
NUCLEIC ACIDS ENCODING A HUMAN MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO IL-1a
App 20140186943 - Simard; John
2014-07-03
Treating Vascular Disease And Complications Thereof
App 20140099321 - Simard; John
2014-04-10
Treatment of Diabetes
App 20140086933 - Simard; John
2014-03-27
Inhibiting cell migration
Grant 8,679,489 - Simard March 25, 2
2014-03-25
Treatment of Psychiatric Conditions
App 20130287788 - Simard; John
2013-10-31
Modulation of pathogenic CD14+/CD16+ monocytes
Grant 8,546,331 - Simard October 1, 2
2013-10-01
Treatment Of Cachexia By Targeting Interleukin-1 Beta
App 20130195877 - Simard; John
2013-08-01
Interleukin-1 Alpha Antibodies and Methods of Use
App 20130177982 - Simard; John
2013-07-11
Interleukin-1 Alpha Antibodies and Methods of Use
App 20130171728 - Simard; John
2013-07-04
Cachexia Treatment
App 20130078258 - Simard; John
2013-03-28
Interleukin-1 alpha antibodies and methods of use
Grant 8,388,956 - Simard March 5, 2
2013-03-05
Interleukin-1 alpha antibodies and methods of use
Grant 8,388,969 - Simard March 5, 2
2013-03-05
Treatment of Inflammatory Skin Disease and Psychiatric Conditions
App 20130039921 - Simard; John
2013-02-14
Identifying Affinity-Matured Human Antibodies
App 20130018173 - Simard; John
2013-01-17
Modulation of Pathogenic Monocytes
App 20120276110 - Simard; John
2012-11-01
Treatment of Dermatological Pathologies
App 20120251548 - Simard; John
2012-10-04
Diagnosis, treatment, and prevention of vascular disorders using interleukin-1 autoantibodies
App 20120231012 - Simard; John ;   et al.
2012-09-13
Modulation of the amount or function of pathogenic CD14+CD16+ monocytes
Grant 8,242,074 - Simard August 14, 2
2012-08-14
Interleukin-1 Alpha Antibodies and Methods of Use
App 20120164665 - Simard; John
2012-06-28
Diagnosis, treatment, and prevention of vascular disorders using IL-1 autoantibodies
Grant 8,187,817 - Simard , et al. May 29, 2
2012-05-29
IL-1alpha immunization induces autoantibodies protective against atherosclerosis
App 20120114598 - Simard; John
2012-05-10
Characterizing an allotypic phenotype of a subject
App 20120094301 - Simard; John
2012-04-19
Methods for identifying a subject who has developed an anti-antibody response
App 20120094395 - Simard; John
2012-04-19
Treatment for Neoplastic Diseases
App 20120045444 - SIMARD; John
2012-02-23
Interleukin-1 Alpha Antibodies and Methods of Use
App 20120021512 - Simard; John
2012-01-26
Interleukin-1 Alpha Antibodies and Methods of Use
App 20120014971 - Simard; John
2012-01-19
Interleukin-1 Alpha Antibodies and Methods of Use
App 20120015384 - Simard; John
2012-01-19
Interleukin-1 Alpha Antibodies and Methods of Use
App 20120015433 - Simard; John
2012-01-19
Arthritis Treatment
App 20110311547 - Simard; John
2011-12-22
Interleukin-1.alpha. antibodies
Grant 8,034,337 - Simard October 11, 2
2011-10-11
Method of selecting a monoclonal antibody for administration
App 20110070229 - Simard; John
2011-03-24
Method and devices for identifying and treating a subject who has developed an anti-antibody response
App 20110070230 - Simard; John
2011-03-24
Method of modifying a monoclonal antibody
App 20110071276 - Simard; John
2011-03-24
Panel of monoclonal antibody containing pharmaceutical compositions
App 20110071054 - Simard; John
2011-03-24
IL-1alpha immunization induces autoantibodies protective against atherosclerosis
App 20110008282 - Simard; John
2011-01-13
Targeting pathogenic monocytes
App 20100068212 - Simard; John
2010-03-18
TREATMENT OF CANCER WITH ANTI-IL-1alpha ANTIBODIES
App 20100040574 - Simard; John
2010-02-18
Interleukin-1 alpha ABS and methods of use
App 20090298096 - Simard; John
2009-12-03
IL-1alpha IMMUNIZATION INDUCES AUTOANTIBODIES PROTECTIVE AGAINST ATHEROSCLEROSIS
App 20090191149 - Simard; John
2009-07-30
Diagnosis, Treatment, And Prevention Of Vascular Disorders Using Il-1 Autoantibodies
App 20090123415 - Simard; John ;   et al.
2009-05-14
Immunogenic compositions derived from poxviruses and methods of using same
App 20060003316 - Simard; John ;   et al.
2006-01-05
Company Registrations
SEC0001639078SIMARD JOHN

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed